test U heeft geen actief abonnement test U heeft geen actief abonnement October 2024 General Read more
2020 April ESMO 2019 Half of the patients with metastatic melanoma treated with nivolumab-ipilimumab are still aliv... Read more
2020 April ASCO 2019 Ramucirumab plus erlotinib improves progression-free survival in EGFR-positive lung cancer Read more
2020 April ASCO 2019 NEOSTAR: pre-surgical checkpoint inhibition effective in early stage lung cancer Read more
2020 April ASCO 2019 FOLFOXIRI + bevacizumab shows progression-free survival benefit in mCRC patients with ≥3 bas... Read more
(sponsored) 2020 February Pharma News Mosunetuzumab effective in heavily pretreated non-Hodgkin lymphoma Read more
2020 February ASCO 2019 Pembrolizumab increases historic survival rate for certain people with advanced NSC lung cance... Read more
Top
